Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level?
- 1Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
- 2Department of Pediatrics, University of Montreal and Endocrinology Service and Research Center, Sainte-Justine Hospital, Montreal, Quebec, Canada
- 3Department of Pediatrics, University of Montreal and Endocrinology Service and Research Center, Montreal, Quebec, Canada
- Correspondence to Dr Scott D Grosse, Centers for Disease Control and Prevention, 1600 Clifton Road, MS E64, Atlanta, GA 30333, USA;
Contributors SDG designed the study, obtained the data, participated in the data analysis, contributed to the discussion and wrote the manuscript with GVV. GVV contributed to the discussion and wrote the manuscript with SDG. Both authors read and approved the final manuscript.
- Accepted 16 November 2010
- Published Online First 17 January 2011
Objective Congenital hypothyroidism (CHT) is a common cause of preventable mental retardation, and the quantification of intellectual disability due to CHT is needed to assess the public health benefit of newborn screening.
Design Review of published studies conducted among children born prior to the introduction of newborn screening for CHT and reporting cognitive test scores.
Setting Population-based studies.
Patients Children with clinically diagnosed CHT.
Interventions Thyroid hormone substitution.
Main outcome measures Intelligence quotient (IQ) (mean and distribution).
Results The prevalence of recognised CHT rose from one in 6500 prior to screening to approximately one in 3000 with screening. In four population-based studies in high-income countries, among children with clinically diagnosed CHT 8–28% were classified as having intellectual disability (defined as an IQ <70) and the mean IQ was 85 (a leftward shift of 1 SD). Among children with subclinical CHT, the risk of overt intellectual disability was lower (zero in one study), but decreased intellectual potential and increased behavioural abnormalities were documented.
Conclusions Although the prevalence of overt disability among children with CHT in the absence of screening may be less than previously estimated, the preventable burden of intellectual disability due to CHT is substantial and justifies newborn screening. However, changes in existing newborn screening protocols to capture more cases are unlikely to prevent overt cases of disability and should therefore be justified instead by the documentation of other benefits of early detection.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.